Yale University, United States
Akiko Iwasaki, Ph.D., is a Sterling Professor of Immunobiology and Molecular, Cellular, and Developmental Biology at Yale University, and an Investigator of the Howard Hughes Medical Institute. She received her Ph.D. from the University of Toronto in Canada and her postdoctoral training from the National Institutes of Health. Her research focuses on the mechanisms of immune defense against viruses at the mucosal surfaces, and the development of mucosal vaccine strategies. She is the co-Lead Investigator of the Yale COVID-19 Recovery Study, which aims to determine the changes in the immune response of people with long COVID after vaccination. Dr. Iwasaki’s team developed ERVMap to analyze expression of endogenous retroviruses and found ERV-reactive antibodies that stimulate neutrophil phagocytosis and NETosis in lupus patients. Dr. Iwasaki was elected to the National Academy of Sciences in 2018, to the National Academy of Medicine in 2019, to the European Molecular Biology Organization in 2021, and to the American Academy of Arts and Sciences in 2021. She is currently the director of Yale Center for Infection and Immunity.
Disclosure information not submitted.
Wednesday, June 22, 2022
11:30 AM – 1:00 PM PT
